A Study to Evaluate the Changes of Pulmonary Function Test (PFT) and Whether the Change of PFT is Associated with the Development of Non-infectious Pneumonitis in Patients with Metastatic Renal Cell Carcinoma Treated with Everolimus

Trial Profile

A Study to Evaluate the Changes of Pulmonary Function Test (PFT) and Whether the Change of PFT is Associated with the Development of Non-infectious Pneumonitis in Patients with Metastatic Renal Cell Carcinoma Treated with Everolimus

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Dec 2015

At a glance

  • Drugs Everolimus (Primary)
  • Indications Renal cell carcinoma
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top